-+ 0.00%
-+ 0.00%
-+ 0.00%

U.S. FDA APPROVES GILEAD’S BIXLENVO™, A NEW ONCE-DAILY SINGLE TABLET OPTION FOR VIROLOGICALLY SUPPRESSED ADULTS WITH HIV, INCLUDING THOSE ON COMPLEX REGIMENS

路透·08/27/2026 21:47:00

登录查看新闻详情